Rebecca Shatsky

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Novaritis
    Topic:
    CDK4/6 inhibitors
    Date added:
    01/09/2025
    Date updated:
    01/09/2025
    Relationship end date:
    12/13/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Gilead
    Topic:
    Clinical Trial
    Date added:
    01/09/2025
    Date updated:
    01/09/2025
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Lilly
    Topic:
    Social Media
    Date added:
    01/09/2025
    Date updated:
    01/09/2025
    Relationship end date:
    09/15/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    AstraZeneca
    Topic:
    PARP inhibitors
    Date added:
    01/09/2025
    Date updated:
    01/09/2025
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Stemline
    Topic:
    SERDS
    Date added:
    01/09/2025
    Date updated:
    01/09/2025
    Relationship end date:
    08/16/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    OBI Pharmaceuticals
    Topic:
    Clinical Trial
    Date added:
    01/09/2025
    Date updated:
    01/09/2025
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    AstraZeneca
    Topic:
    Clinical Trial
    Date added:
    01/09/2025
    Date updated:
    01/09/2025
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    TEMPUS
    Topic:
    Germline sequencing
    Date added:
    01/09/2025
    Date updated:
    01/09/2025
    Relationship end date:
    12/08/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Guardant
    Topic:
    MRD testing
    Date added:
    01/09/2025
    Date updated:
    01/09/2025
    Relationship end date:
    05/31/2024
Return to Best of Hematology and Breast Cancer 2025, San Diego